The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paterson, G.
Right arrow Articles by Willison, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paterson, G.
Right arrow Articles by Willison, H. J.

The Journal of Immunology, Vol 155, Issue 6 3049-3059, Copyright © 1995 by American Association of Immunologists


ARTICLES

Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation

G Paterson, G Wilson, PG Kennedy and HJ Willison
University of Glasgow Department of Neurology, Southern General Hospital, Scotland, United Kingdom.

Serum anti-GM1 ganglioside Abs are abnormally elevated in patients with chronic motor neuropathies and Guillain-Barre syndrome. We have cloned six anti-GM1 IgM Abs from PBMCs of five affected patients. VH and VL gene analysis demonstrated substantial somatic mutation, predominantly clustered around VH CDR2 and FR3 in all six Abs. The Abs SM1, DO1, and WO1, isolated from three different patients, are encoded by closely related VH gene segments with restricted canonical structures. The corresponding L chains are encoded by V lambda II and V lambda VIII genes and also share the same canonical structures, containing nucleotide deletions at the VL/JL boundary to form a VLCDR3 of 10 amino acids. DO1 and WO1 VH segments show nucleotide identities of 95.6% and 88.8%, respectively, to the VH3 member 1.9III, and SM1 shows 87.8% identity to the closely related VH3 member, Hv3005. The Abs BO1 and BO3, derived from a single patient and containing the same VH-D-JH and VL-JL rearrangements, are encoded by the VH3 gene, HHg19, with nucleotide identities of 92.2 and 91.2%, respectively, and have both common and unique somatic mutations. The VH sequence of BR1 has 91.3% identity to the VH4 member, V71-2. These data indicate that neuropathy- associated anti-GM1 IgM Abs can be encoded by both diverse and closely related V genes in association with restricted canonical structures, and that their V genes are somatically mutated, consistent with an origin through an Ag-driven immune response.


This article has been cited by other articles:


Home page
GlycobiologyHome page
K. Townson, K. N Greenshields, J. Veitch, D. Nicholl, M. Eckhardt, O. Galanina, N. Bovin, E. Samain, T. Antoine, D. Bundle, et al.
Sulfatide binding properties of murine and human antiganglioside antibodies
Glycobiology, November 1, 2007; 17(11): 1156 - 1166.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. Booman, J. Douwes, M.-C. Legdeur, J. van Baarlen, E. Schuuring, and P. Kluin
From brain to testis: immune escape and clonal selection in a B cell lymphoma with selective out-growth in two immune sanctuariesy
Haematologica, June 1, 2007; 92(6): e69 - e71.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Kirvan, C. J. Cox, S. E. Swedo, and M. W. Cunningham
Tubulin Is a Neuronal Target of Autoantibodies in Sydenham's Chorea
J. Immunol., June 1, 2007; 178(11): 7412 - 7421.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Goodfellow, T. Bowes, K. Sheikh, M. Odaka, S. K. Halstead, P. D. Humphreys, E. R. Wagner, N. Yuki, K. Furukawa, K. Furukawa, et al.
Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy
J. Neurosci., February 16, 2005; 25(7): 1620 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. E. Alaniz, R. D. Lardone, S. L. Yudowski, M. I. Farace, and G. A. Nores
Normally Occurring Human Anti-GM1 Immunoglobulin M Antibodies and the Immune Response to Bacteria
Infect. Immun., April 1, 2004; 72(4): 2148 - 2151.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. W. Ang, J. D. Laman, H. J. Willison, E. R. Wagner, H. P. Endtz, M. A. De Klerk, A. P. Tio-Gillen, N. Van den Braak, B. C. Jacobs, and P. A. V. Doorn
Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barre and Miller Fisher Patients
Infect. Immun., March 1, 2002; 70(3): 1202 - 1208.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. M. Prendergast and A. P. Moran
Review: Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies
Innate Immunity, October 1, 2000; 6(5): 341 - 359.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
M. M. Prendergast, H. J. Willison, and A. P. Moran
Human Monoclonal Immunoglobulin M Antibodies to Ganglioside GM1 Show Diverse Cross-Reactivities with Lipopolysaccharides of Campylobacter jejuni Strains Associated with Guillain-Barre Syndrome
Infect. Immun., July 1, 1999; 67(7): 3698 - 3701.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Paparounas, G. M. O'Hanlon, C. P. O'Leary, E. G. Rowan, and H. J. Willison
Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro
Brain, May 1, 1999; 122(5): 807 - 816.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
R. H. Quarles
The Spectrum and Pathogenesis of Antibody-mediated Neuropathies
Neuroscientist, May 1, 1997; 3(3): 195 - 204.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.